An Open-Label, Two-Period, Fixed-Sequence Study to Evaluate the Effect of Multiple Doses of Ketoconazole on the Single Dose Pharmacokinetics of CC-223 in Healthy Adult Male Subjects
Latest Information Update: 13 Nov 2019
At a glance
- Drugs Onatasertib (Primary) ; Ketoconazole
- Indications Multiple myeloma; Non-Hodgkin's lymphoma; Non-small cell lung cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Celgene Corporation
- 03 Apr 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
- 16 Jul 2013 New trial record